Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib

被引：0
|
作者：
Robier, Christoph [1 ,2 ]
Beham-Schmid, Christine [3 ]
Neubauer, Manfred [4 ]
机构：
[1] Hosp Bros St John God, Inst Lab Diagnost, Bergstr 27, A-8020 Graz, Austria
[2] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria
[3] Med Univ Graz, Inst Pathol, Graz, Austria
[4] Hosp Bros St John God, Dept Internal Med, Graz, Austria
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2018年 / 56卷 / 05期
关键词：
chronic lymphocytic leukemia; CLL; ibrutinib; lymphocytes; lymphocyte agglutination; pseudoerythroblastemia; pseudolymphopenia; PERIPHERAL-BLOOD; CELLS; ANALYZERS; CLUSTERS;
D O I：
10.1515/cclm-2017-0836
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：E112 / E114
页数：3
相关论文
共 50 条
  • [1] Fatal Cryptococcal Meningitis in a Patient With Chronic Lymphocytic Leukemia Treated With Ibrutinib
    Oumayma, Hari
    Mahtat, El Mehdi
    Bouh, Hawa Moussa
    Elmaaroufi, Hicham
    Doghmi, Kamal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [2] CHRONIC LYMPHOCYTIC-LEUKEMIA WITH LOW LYMPHOCYTE COUNT
    BATATA, A
    SHEN, B
    CANCER, 1993, 71 (09) : 2732 - 2738
  • [3] Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinib
    Smith, David D.
    Goldstein, Leanne
    Cheng, Mei
    James, Danelle F.
    Kunkel, Lori A.
    Fardis, Maria
    Hamdy, Ahmed
    Izumi, Raquel
    Buggy, Joseph J.
    Clow, Fong
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 249 - 256
  • [4] Modeling absolute lymphocyte counts after treatment of chronic lymphocytic leukemia with ibrutinib
    David D. Smith
    Leanne Goldstein
    Mei Cheng
    Danelle F. James
    Lori A. Kunkel
    Maria Fardis
    Ahmed Hamdy
    Raquel Izumi
    Joseph J. Buggy
    Fong Clow
    Annals of Hematology, 2015, 94 : 249 - 256
  • [5] Pharmacokinetics of ibrutinib in a patient with chronic lymphocytic leukemia on hemodialysis
    Ohtani, Toyoji
    Tani, Akiko
    Namme, Yuki
    Namme, Rie
    Hirose, Maki
    Shingu, Ikuo
    Kizawa, Yusuke
    Endo, Akira
    Yasu, Takeo
    CLINICAL NEPHROLOGY, 2022, 98 (06) : 301 - 304
  • [6] Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia
    Beresford, Rohan
    Dolot, Virginia
    Foo, Hong
    MEDICAL MYCOLOGY CASE REPORTS, 2019, 24 : 27 - 29
  • [7] EXPERIENCE OF IBRUTINIB THERAPY IN THE TREATMENT OF PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kurkina, N. V.
    Repina, E. A.
    Mashnina, N. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (01): : 55 - 56
  • [8] Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
    Mauro, Francesca Romana
    Giannarelli, Diana
    Visentin, Andrea
    Reda, Gianluigi
    Sportoletti, Paolo
    Frustaci, Anna Maria
    Chiarenza, Annalisa
    Ciolli, Stefania
    Vitale, Candida
    Laurenti, Luca
    De Paoli, Lorenzo
    Murru, Roberta
    Gentile, Massimo
    Rigolin, Gian Matteo
    Levato, Luciano
    Giordano, Annamaria
    Del Poeta, Giovanni
    Stelitano, Caterina
    Ielo, Claudia
    Noto, Alessandro
    Guarente, Valerio
    Molica, Stefano
    Coscia, Marta
    Tedeschi, Alessandra
    Gaidano, Gianluca
    Cuneo, Antonio
    Foa, Robin
    Martelli, Maurizio
    Girmenia, Corrado
    Gentile, Giuseppe
    Trentin, Livio
    CANCERS, 2021, 13 (13)
  • [9] Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib
    Sittig, Katherine R.
    Laageide, Leah G.
    Akhtar, Zaheer
    Wall, Geoffrey C.
    Kumar, Sudhir C.
    IDCASES, 2021, 24
  • [10] Ibrutinib for the treatment of chronic lymphocytic leukemia
    Deodato, Marina
    Frustaci, Anna Maria
    Zamprogna, Giulia
    Cairoli, Roberto
    Montillo, Marco
    Tedeschi, Alessandra
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (05) : 273 - 284
12345